188 related articles for article (PubMed ID: 2123450)
1. Three-dimensional structure determination of an anti-2-phenyloxazolone antibody: the role of somatic mutation and heavy/light chain pairing in the maturation of an immune response.
Alzari PM; Spinelli S; Mariuzza RA; Boulot G; Poljak RJ; Jarvis JM; Milstein C
EMBO J; 1990 Dec; 9(12):3807-14. PubMed ID: 2123450
[TBL] [Abstract][Full Text] [Related]
2. In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation.
Figini M; Marks JD; Winter G; Griffiths AD
J Mol Biol; 1994 May; 239(1):68-78. PubMed ID: 8196048
[TBL] [Abstract][Full Text] [Related]
3. Preliminary crystallographic study of the Fab fragments of two monoclonal anti-2-phenyloxazolone antibodies.
Mariuzza RA; Boulot G; Guillon V; Poljak RJ; Berek C; Jarvis JM; Milstein C
J Biol Chem; 1985 Aug; 260(18):10268-70. PubMed ID: 4019512
[TBL] [Abstract][Full Text] [Related]
4. Several V genes participate in the early phenyloxazolone response in various combinations.
Kaartinen M; Pelkonen J; Mäkelä O
Eur J Immunol; 1986 Jan; 16(1):98-105. PubMed ID: 3081356
[TBL] [Abstract][Full Text] [Related]
5. V genes of the primary antibody response of C57BL/10 mice to the hapten phenyloxazolone.
Kaartinen M; Pelkonen E; Even J; Mäkelä O
Eur J Immunol; 1988 Jul; 18(7):1095-100. PubMed ID: 3136024
[TBL] [Abstract][Full Text] [Related]
6. "Diabodies": small bivalent and bispecific antibody fragments.
Holliger P; Prospero T; Winter G
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
[TBL] [Abstract][Full Text] [Related]
7. Fabs specific for 8-oxoguanine: control of DNA binding.
Bespalov IA; Bond JP; Purmal AA; Wallace SS; Melamede RJ
J Mol Biol; 1999 Nov; 293(5):1085-95. PubMed ID: 10547287
[TBL] [Abstract][Full Text] [Related]
8. Molecular modelling study of antigen binding to oxazolone-specific antibodies: the Ox1 idiotypic IgG and its mature variant with increased affinity to 2-phenyloxazolone.
Holm L; Laaksonen L; Kaartinen M; Teeri TT; Knowles JK
Protein Eng; 1990 Apr; 3(5):403-9. PubMed ID: 2349210
[TBL] [Abstract][Full Text] [Related]
9. Variable region primary structures of a high affinity anti-fluorescein immunoglobulin M cryoglobulin exhibiting oxazolone cross-reactivity.
Dombrink-Kurtzman MA; Johnson LS; Riordan GS; Bedzyk WD; Voss EW
J Biol Chem; 1989 Mar; 264(8):4513-22. PubMed ID: 2494173
[TBL] [Abstract][Full Text] [Related]
10. EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies.
Cooke HA; Arndt J; Quan C; Shapiro RI; Wen D; Foley S; Vecchi MM; Preyer M
MAbs; 2018; 10(8):1248-1259. PubMed ID: 30215570
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of the maternally induced affinity enhancement in the non-Ox1 idiotypic antibody repertoire of the primary immune response to 2-phenyloxazolone.
Lange H; Kobarg J; Yazynin S; Solterbeck M; Henningsen M; Hansen H; Lemke H
Scand J Immunol; 1999 Jan; 49(1):55-66. PubMed ID: 10023858
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the affinity maturation of antibody 48G7.
Yang PL; Schultz PG
J Mol Biol; 1999 Dec; 294(5):1191-201. PubMed ID: 10600377
[TBL] [Abstract][Full Text] [Related]
14. The immunological evolution of catalysis.
Patten PA; Gray NS; Yang PL; Marks CB; Wedemayer GJ; Boniface JJ; Stevens RC; Schultz PG
Science; 1996 Feb; 271(5252):1086-91. PubMed ID: 8599084
[TBL] [Abstract][Full Text] [Related]
15. Structure and specificity of the anti-digoxin antibody 40-50.
Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of the immunological evolution of antibody 28B4.
Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG
Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051
[TBL] [Abstract][Full Text] [Related]
17. Use of 2D NMR, protein engineering, and molecular modeling to study the hapten-binding site of an antibody Fv fragment against 2-phenyloxazolone.
McManus S; Riechmann L
Biochemistry; 1991 Jun; 30(24):5851-7. PubMed ID: 2043627
[TBL] [Abstract][Full Text] [Related]
18. Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis.
Potter KN; Thomson RK; Hamblin A; Richards SD; Lindsay JG; Stevenson FK
J Mol Biol; 2001 Feb; 306(1):37-46. PubMed ID: 11178892
[TBL] [Abstract][Full Text] [Related]
19. Light chain germ-line genes and the immune response to 2-phenyloxazolone.
Even J; Griffiths GM; Berek C; Milstein C
EMBO J; 1985 Dec; 4(13A):3439-45. PubMed ID: 3937727
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36-71. 1. X-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten.
Strong RK; Campbell R; Rose DR; Petsko GA; Sharon J; Margolies MN
Biochemistry; 1991 Apr; 30(15):3739-48. PubMed ID: 2015229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]